Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001104659-24-119763
Filing Date
2024-11-15
Accepted
2024-11-15 17:01:15
Documents
7

Document Format Files

Seq Description Document Type Size
1 F-1 tm2428455-1_f1.htm F-1 533405
2 EXHIBIT 5.1 tm2428455d2_ex5-1.htm EX-5.1 11978
3 EXHIBIT 23.1 tm2428455d2_ex23-1.htm EX-23.1 2695
4 EX-FILING FEES tm2428455d2_ex-filingfees.htm EX-FILING FEES 17503
5 GRAPHIC tm2428455d2_ex5-1img001.jpg GRAPHIC 11520
6 GRAPHIC tm2428455d2_ex5-1img002.jpg GRAPHIC 1945
7 GRAPHIC lg_xortxtherapeutics-4clr.jpg GRAPHIC 26290
  Complete submission text file 0001104659-24-119763.txt   621850
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-283275 | Film No.: 241468738
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)